Jenscare Scientific Co Ltd (9877)

Currency in HKD
7.20
+0.03(+0.42%)
Closed·
9877 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.187.20
52 wk Range
6.0011.98
Key Statistics
Bid/Ask
6.91 / 7.20
Prev. Close
7.2
Open
7.18
Day's Range
7.18-7.2
52 wk Range
6-11.98
Volume
7K
Average Volume (3m)
164.17K
1-Year Change
-20.5298%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
9877 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Jenscare Scientific Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Mar 26, 2026
EPS / Forecast
-0.23 / --
Revenue / Forecast
77.16M / --
EPS Revisions
Last 90 days

9877 Income Statement

Compare 9877 to Peers and Sector

Metrics to compare
9877
Peers
Sector
Relationship
P/E Ratio
−9.5x19.4x−0.4x
PEG Ratio
0.200.040.00
Price/Book
3.3x2.4x2.6x
Price / LTM Sales
28.4x4.0x3.1x
Upside (Analyst Target)
-49.1%47.5%
Fair Value Upside
Unlock22.6%5.9%Unlock

Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People’s Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; Ken-Valve, a TRVR system for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve intervention (TMVR) repair system to treat patients with severe mitral regurgitation; JensRelive, a TMVR system to treat patients with severe mitral regurgitation and replace dysfunctional primary mitral valves without undergoing routine thoracotomy surgery; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it offers platform technologies/accessories comprising introducer kit, JeniGal anti-calcification technology, dry-tissue technology and polymer leaflet technology; and engages in consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People’s Republic of China.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
300.60K0.07%2.15M
Other Institutional Investors
162.85M39.04%1.17B
Public Companies & Retail Investors
253.95M60.88%1.82B
Total
417.1M100.00%2.99B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Jenscare Scientific Co., Ltd., ESOP18.17%75,773,170542,536
Hillhouse Investment Management, Ltd.7.61%31,725,000227,151

FAQ

What Is the Jenscare Scientific (9877) Stock Price Today?

The Jenscare Scientific stock price today is 7.20 HKD.

What Stock Exchange Does Jenscare Scientific Trade On?

Jenscare Scientific is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Jenscare Scientific?

The stock symbol for Jenscare Scientific is "9877."

What Is the Jenscare Scientific Market Cap?

As of today, Jenscare Scientific market cap is 3.00B HKD.

What Is Jenscare Scientific's Earnings Per Share (TTM)?

The Jenscare Scientific EPS (TTM) is -0.64.

From a Technical Analysis Perspective, Is 9877 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Jenscare Scientific Stock Split?

Jenscare Scientific has split 0 times.

What is the current trading status of Jenscare Scientific (9877)?

As of Aug 13, 2026, Jenscare Scientific (9877) is trading at a price of 7.20 HKD, with a previous close of 7.20 HKD. The stock has fluctuated within a day range of 7.18 HKD to 7.20 HKD, while its 52-week range spans from 6.00 HKD to 11.98 HKD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.